期刊文献+

微量白蛋白尿的临床应用研究进展 被引量:7

Research Progress on Risk Estimate Factor of Microalbuminuria
下载PDF
导出
摘要 微量白蛋白尿(MAlb)是近年来国内外的研究热点,通过研究发现,它与许多疾病的发生、发展有关。目前国内外研究最多是它已成为多种疾病的危险预测因子,尤其在心血管疾病预后方面,是非常有价值的临床预测指标。本文通过查阅国内外最新文献资料,探讨微量白蛋白尿(MAlb)的检测方法、临床应用以及最新研究进展。 Microalbuminuria(MAlb)is a research focus at domestic and abroad in recent years. The re- search shows it is with the development of many diseases. Currently, most studied is MAlb. It has become a predictor of the risk of many diseases, Especially in cardiovascular disease prognosis is extremely valuable clinical predictor. The articles access to the latest domestic and foreign literature, approach the phenomenon of heart rate turbulence at the mechanism and clinical application and recent advances.
出处 《内蒙古医学杂志》 2012年第4期464-466,510,共3页 Inner Mongolia Medical Journal
基金 内蒙古科技攻关项目(20070501)
关键词 微量白蛋白尿 危险预测因子 Microalbuminuria Risk estimate factor Cardiovascular disease
  • 相关文献

参考文献28

  • 1Hartland A, Gosling P. Microalbumlnuria: yet another cardiovascular risk factor[J]. Ann Clin Biochem, 1999, 36(6) : 700 - 703.
  • 2Price CP, Newman DJ, Blirup - JensenS, et al. First International Reference Preparation for Individual Proteins in Urine. IFCC Working Group on Urine Proteins. International Federation of Clinical Chemistry[ J ]. Clin Biochem, 1998, 31 (6) : 467 - 474.
  • 3Deckert T. Nephropathy and coronary death - the fatal twins in diabetes mellitus[J]. Nephrol Dial Transplant, 1994, 9(8) : 1 069 - 1 071.
  • 4Parring HH, Andersen S, Jacobsen P, et al. Angiotensin receptor blockers in diabetic nephropathy: renal and cardiovascular end points[J]. Semin Nephrol, 2004, 24(2) : 147 - 157.
  • 5DeJong PE, Hillege HL, Pinto - Sietsma SJ, et al. Screening- formicroalbuminuria in the general population: a tool to detect subjectsat risk for progressive renal failure in an early phase[J]. Nephrol Dial Transplant, 2003, 18(1) :10 - 13.
  • 6Mann JF, Gerstein HC, Pogue J, et al. Renal insufficiency as a predictor of cardiovascular outcomes and the impact of ramipril : the HOPE randomized trial[J]. Ann Intern Med, 2001, 134(8) : 629 - 636.
  • 7Segura J. Campo IC, RuilopeI M. Chroie kidney disease and global card 10 vaseular risk in essential hypertension[J]. Minerva Med, 2004, 95(5) 375 - 383.
  • 8Martin Tdan - Christian R, Bobby V. Abdominal obesity is associated with microalbuminuria and an elevated cardiovascular risk profile in pati - ents with hypertension [ J ]. Vasc Health Risk Manag, 2009, 5(4) :577 - 585.
  • 9倪红辉.血清同型半胱氨酸及尿微量白蛋白与2型糖尿病肾病的相关性研究[J].实验与检验医学,2008,26(5):583-583. 被引量:7
  • 10朱敏.尿微量蛋白测定对诊断肾脏损伤的探讨[J].江西医学检验,2007,25(3):275-275. 被引量:7

二级参考文献17

  • 1顾春瑜,郑磊,王前.血清胱抑素C在评价肾移植患者肾功能中的应用[J].国外医学(临床生物化学与检验学分册),2004,25(6):559-561. 被引量:64
  • 2裘红梅,赵彩红,宋光.联合检测尿液α_1-MG、NAG及尿液Cystatin C对肾损害早期诊断的临床意义[J].大连大学学报,2007,28(3):93-94. 被引量:6
  • 3王海燕.原发性肾小球疾病分型与治疗及判断标准专题座谈会纪要[J].中华内科杂志,1993,32(2):131-134.
  • 4周新,涂植光.临床生物化学和生物化学检验.北京:人民卫生出版社,2004:177.
  • 5Dhamidharka VR, Kwon G, Stevens G. Serum cystatin C is superior to serum creatinine as a marker of kidney function: a meta-analysis[ J]. Am J Kidney Dis,2002,40(2) :221-226.
  • 6[2]J Graham IM,Daly LE,Refsum HM,et al.Plsama homocysteine as a risk factor vascular disease.The European Concerted Action Project[J].JAM.A,1997,39(22):1390.
  • 7[4]Ozmen B,Ozmen D,Turgan N,et al.Associaton between homocysteinemia and renal function in patients with type 2 diabetes mellitus[J].Ann Clin Lab Sci,2002,32:279~286.
  • 8[5]Hoogeveen EK,Kostense PJ,Jager A,et al.Serum homocysteine level and protein intake are related to risk of microalbuminuria:The Hoom study[J].Kidney Int,1998,54(1):203~209.
  • 9[6]Lanfredini M,Fiorina P,Peca MG,et al.Fasting and postmethionine load homocysteine values are correlated with microalbuminuria and contribute to worsening vascular damage in non-insulin-dependent diabetes mellitus patients[J].Metabolism,1998,47(8):915~921.
  • 10[7]Wall RT,Harlan JM,Harker LA,et al.Homoeysteine-induced endothelial cell injury in vivo:a model for the study of vascular injury[J].Thromb Res,1980,18(1-2):113~121.

共引文献74

同被引文献47

  • 1鲍浩,王庆文.对微量白蛋白尿的重新认识[J].肾脏病与透析肾移植杂志,2006,15(6):556-560. 被引量:2
  • 2周秀荣,徐荣,张兰萍,王哲鹏,王东欣.原发性高血压早期肾损伤尿微量白蛋白检测的临床意义[J].中国初级卫生保健,2007,21(6):89-90. 被引量:2
  • 3朱敏.尿微量蛋白测定对诊断肾脏损伤的探讨[J].江西医学检验,2007,25(3):275-275. 被引量:7
  • 4卢传辉,尤俊,刘静,洪明,许林,张志明.射频消融术和手术对原发性肝癌体内细胞免疫状态变化的影响[J].中华肿瘤防治杂志,2007,14(15):1146-1148. 被引量:13
  • 5Ohno I, Hosoya T, Gomi H, et al. Serum uric acid andrenal prognosis in IgA nephropathy [J]. Nephron,2001,87( 12) : 333-339.
  • 6Iseki K, Oshiro S, Tozawa M, et al. Significance ofhyper uricemia on the early detection of renal failure in acohort of screened subjects[J]. Hypertens Res, 2001,24(17): 691-697.
  • 7Tomita M, Mizuno S, Y amanaka H, et al. Does hyperuriecmia affect nortality A prospective cohostudy of Japanesemale workers[J]. J Epidemiol, 2000, 10: 403-409.
  • 8Verhave JC, Gansevoot RT,Hillege HL,et al.Anelevated uri nary albumin excretion predicts de novodevelopment of renal function impairment in the generalpopulation [J]. Kidney Int Suppl, 2004,92(7) : 18-21.
  • 9Ohno I, Hosoya T, Gomi H, et al. Serum uric acid and renal prog- nosis in patients with IgA nephropathy. Nephron, 2001,87 (4) : 333 -339.
  • 10Tomita M, Mizuno S, Yamanaka H, et al. Does hyperuricemia af- fect mortality A prospective cohort study of Japanese male workers. J Epidemiol, 2000, l0 ( 6 ) :403-409.

引证文献7

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部